The experimental antiviral drug remdesivir shortened hospital stays for seriously ill COVID-19 patients in a federally funded study. But there's not enough of the medicine to go around. Ulrich Perrey/Pool/AFP via Getty Images hide caption toggle caption Ulrich Perrey/Pool/AFP via Getty Images The experimental antiviral drug remdesivir shortened hospital stays for seriously ill COVID-19 patients…
Complaints about hospital food are certainly not new, and Jell-O and fruit juice are often the butt of related jokes. But the Trump administration has recently upped the ante. It is urging the public to report hospitals and nursing homes that serve sugary drinks, nutrition shakes, or meals that it says don’t meet dietary guidelines
You don't have permission to access "http://www.medpagetoday.com/primarycare/uritheflu/121074" on this server. Reference #18.9177d917.1777813366.6dbceef7 https://errors.edgesuite.net/18.9177d917.1777813366.6dbceef7
Céline Gounder, KFF Health News’ editor-at-large for public health, discussed the results of the FDA’s largest baby formula safety test on CBS News 24/7’s The Daily Report on April 29. She also discussed how women seeking treatment for menopause symptoms are facing a shortage of estrogen patches on CBS News’ CBS Mornings on April 27.